|
Volumn 322, Issue 7282, 2001, Pages 329-333
|
Antiplatelet drugs for prevention of pre-eclampsia and its consequences: Systematic review
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
PLACEBO;
ARTICLE;
CHILDBIRTH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FETUS RISK;
FOLLOW UP;
GESTATIONAL AGE;
HUMAN;
MAJOR CLINICAL STUDY;
NEWBORN DEATH;
PREECLAMPSIA;
PREMATURE LABOR;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
SMALL FOR DATE INFANT;
TREATMENT OUTCOME;
|
EID: 0035835423
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.322.7282.329 Document Type: Article |
Times cited : (218)
|
References (22)
|